XML 32 R65.htm IDEA: XBRL DOCUMENT

Earnings per share (Tables)

12 Months Ended

Jun. 30, 2019

Text block [abstract]

Summary of earnings per share


		2019 A$’000				2018 A$’000				2017 A$’000

Loss after income tax attributable to the owners of Kazia Therapeutics Limited			(10,270	)			(6,039	)			(10,670	)

Loss after income tax attributable to the owners of Kazia Therapeutics Limited			(10,270	)			(6,039	)			(10,670	)


		Number				Number				Number

Weighted average number of ordinary shares used in calculating basic earnings per share			57,503,555				48,376,525				467,833,849

Weighted average number of ordinary shares used in calculating Diluted earnings per share			57,503,555				48,376,525				467,833,849


		Cents				Cents				Cents
Basic earnings per share			(17.86	)			(12.48	)			(2.28	)
Diluted earnings per share			(17.86	)			(12.48	)			(2.28	)